Global Cord Blood (NYSE:CO) Coverage Initiated by Analysts at StockNews.com

StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO) in a report issued on Tuesday. The firm issued a strong-buy rating on the medical research company’s stock.

Global Cord Blood Stock Performance

CO opened at $1.50 on Tuesday. Global Cord Blood has a one year low of $2.03 and a one year high of $5.50. The stock’s 50 day moving average price is $1.32 and its 200-day moving average price is $1.40. The stock has a market cap of $182.33 million, a price-to-earnings ratio of 2.34 and a beta of 0.16.

About Global Cord Blood

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants.